MedShadow ArticlesInside the FDA Drug Development Process: The Limits of Clinical Trials in Preventing Side EffectsDaphne Berryhill
MedicationsINVESTIGATING GENERICS: Hundreds Of Drugs Remain On The Market After Fraudulent TrialsEmma Yasinski
MedShadow ArticlesWhat To Know About Cobenfy, First New FDA-Approved Treatment For Schizophrenia in DecadesJessica DiGiacinto
Drug Interactions/Side EffectsHigh Doses of Adderall Raise Risk of Psychosis, New Study ShowsEmma Yasinski
Medication ArticlesFDA Provides Guidance to Pharma Companies for Correcting Social Media MisinformationEmma Yasinski
